https://www.marketscreener.com/quote/stock/ASCENTAGE-PHARMA-GROUP-IN-103501689/news/Live-from-ASH-2023-Ascentage-Pharma-Presents-Updated-Data-from-US-Study-of-Olverembatinib-Further-45549398/?utm_source=telegram&utm_medium=social&utm_campaign=share